110 likes | 116 Views
According to the latest research report by IMARC Group, The global legal cannabis market size reached US$ 20.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 74.5 Billion by 2028, exhibiting a growth rate (CAGR) of 23.9% during 2023-2028.<br><br>More Info:- https://www.imarcgroup.com/legal-cannabis-market
E N D
Global Legal Cannabis Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Legal Cannabis Market Research Report: The latest report by IMARC, titled “Legal Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” finds that the global legal cannabis market size reached US$ 20.7 Billion in 2022. Legal cannabis is a drug obtained from Cannabis Sativa, Indica, and Ruderalis plants. It has psychoactive properties that help relieve chronic pain, regulate and prevent diabetes, alleviate anxiety, and treat depression and inflammatory bowel diseases among individuals. It is also used in the treatment of cancer, multiple sclerosis, arthritis, glaucoma, epilepsy, migraines, Alzheimer’s,Tourette’s, Parkinson, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), and post-traumatic stress disorder (PTSD). Owing to these properties, legal cannabis finds extensive applications across the pharmaceutical industry across the globe. Request Free Sample Report: https://www.imarcgroup.com/legal-cannabis-market/requestsample
Report Description and Highlights Report Description Global Legal Cannabis Market Trends: The market is primarily driven by the increasing number of countries legalizing and decriminalizing cannabis. In addition, oral cannabinoids are effective antiemetics for adults suffering from chemotherapy-induced nausea and vomiting. They are also used to treat spasticity symptoms in individuals with multiple sclerosis (MS)-related spasticity. This, coupled with the expanding pharmaceutical industry worldwide, is positively influencing market growth. Besides this, the market is also propelled by the rising approvals legalizing the use of medications containing cannabidiol (CBD) to treat rare epilepsy like Lennox-Gastaut and Dravet syndrome, which are difficult to control with other types of medication. Moreover, the increasing awareness among individuals regarding the medical benefits of legal cannabis and the rising number of research and clinical trials around the world are also creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 74.5 Billion by 2028, exhibiting a CAGR of 23.9% during the forecast period (2023-2028). Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Report Description and Highlights Report Description Market Summary: Breakup by Source: • Marijuana • Hemp Breakup by Derivatives: • Cannabidiol (CBD) • Tetrahydrocannabinol (THC) Breakup by Distribution Channel: • Recreational Stores • Pharmacies • Online Stores • Others Breakup by End User: • Medical Use • Recreational Use • Industrial Use
Report Description and Highlights Report Description Breakup by Region: • North America • Asia-Pacific • Europe • Latin America • Middle East and Africa
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • • Aurora Cannabis Inc. Cannabis Sativa Inc. Canopy Growth Corporation Green Thumb Industries GW Pharmaceuticals plc (Jazz Pharmaceuticals plc) HEXO Corp. Organigram Holdings Inc. Sundial Growers Inc. The Cronos Group The Green Organic Dutchman Holdings Ltd. The Scotts Miracle-Gro Company Tilray VIVO Cannabis Inc. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/legal-cannabis-market
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com